Skip to content

Amid the technology sector’s summer rebound, we encountered some chatter about a new nickname (Wall Street loves nicknames) that may or may not stick—China’s Prominent 10. Like the Magnificent Seven,1 the “Prom 10” is what Goldman Sachs analysts are calling China’s own power bloc of giant, public-owned enterprises that appear well-positioned to help drive growth and innovation. The corporations span sectors and industries including e-commerce, gaming, media, biotechnology, smartphones and electric vehicles.

What makes the Prominent 10 notable isn’t just their scale or sector reach—but their relatively modest market share. Together, they represent just 17% of China’s total market capitalization, versus far higher concentrations in markets like the United States or Germany.2 The group’s alignment with national policy priorities, including artificial intelligence (AI), consumer technology and global competitiveness, positions them at the forefront of China’s next phase of modernization.

After three straight years of losses (2021–2023), the FTSE China RIC Capped Index is showing signs of a fragile recovery, now up more than 18% in US dollar terms year-to-date through June 26, 2025.3 This is being led by gains in the communications, financials, tech and health care sectors that are prompting investors to shift from China caution to curiosity.

Markets were buoyed recently after the confirmation of a US-China trade framework deal to allow rare-earth exports from China and an easing of US tech restrictions. Of course, a volatile trade environment and US-China tech decoupling may continue to pose challenges for Beijing. Consider, however, that even with World Bank global growth expectations now at 2.3%—a 20-year low outside of major crises—China’s growth forecast remains stable at 4.5%.4

Funding talent

A key driver of China’s progress is its deepening investment in talent and education, particularly in AI and other strategic fields. China’s Ministry of Education has launched a broad campaign to integrate AI education across not just its top-tier universities but also vocational institutions and secondary schools, which stands in contrast to the United States’ unusually strained relationship now between the federal government and higher education institutions. University AI programs in the United States are reportedly experiencing more restrictive federal funding conditions this year and, in several cases, are facing abruptly frozen or canceled National Science Foundation funding for researchers.

According to Stanford University’s 2025 AI Index Report, there has also been a noteworthy reduction in the performance gap between the top AI models of the United States and China—a mere 0.3%. While the United States maintains its lead in quantity, Chinese models have rapidly closed the quality gap: In 2023, China’s top models lagged the United States’ by nearly 20 percentage points in several benchmark tests. Just one year later, this gap has narrowed substantially.

The progress, analysts say, stems from a coordinated national strategy, accelerated investment in AI education and deep integration between state-backed firms and research institutions that are enabling faster commercialization of AI across sectors. In one quirky example, a leading mobile payments and lifestyle app in China has deployed a tool that can help users detect hair loss!

China’s capital expenditure on AI is set to reach upwards of nearly US$99 billion this year, reflecting a surge of 48% over 2024.5 More than half of this funding is expected to come from government sources. Meanwhile, public sentiment is notably more AI-positive in China. Edelman’s 2025 Trust Barometer found that 72% of Chinese respondents say they trust AI, compared to only 32% in the United States—a confidence gap that underscores differences in regulatory environments, infrastructure and cultural adoption.6

In AI They Trust

2024 Study: Percentage Share of Adults Surveyed Who Say They Trust AI Technology

Source: 2025 Edelman Trust Barometer.

Market valuations

Beyond the AI realm, we believe Chinese equity valuations are still reasonable. China’s market (as measured by the MSCI China Index) currently trades at 12.5x forward earnings—below its 10-year average (13.9x) and at a steep discount: 53% to India (as measured by the MSCI India Index), 31% to Taiwan (as measured by the MSCI Taiwan Index) and 18% to the broader emerging market index (as measured by the MSCI Emerging Markets Index).7

This relative undervaluation, paired with an uptick in initial public offering (IPO) activity and tech leadership, makes a strong case for re-engaging with broad China exposures. Hong Kong’s capital markets, long subdued by regulatory uncertainty and sentiment shocks, have also staged a comeback. This indicates to us a resurgence of private sector confidence and a revival in investor demand. We believe that broad China exposures, including both A-Shares and offshore-listed securities, provide a comprehensive opportunity to participate. Given Beijing’s recent progress in US trade negotiations, China’s equity market may finally be transitioning to a more compelling value opportunity, in our analysis.

Diversified Exposures Have Outperformed A-Shares

December 2024–June 2025

Source: Bloomberg. Broad China = FTSE China 30/18 Capped Index, China A = MSCI China A Onshore Index. The FTSE China 30/18 Capped Index represents the performance of Chinese large- and mid-capitalization stocks. The index has a broad coverage of Chinese share classes include A Shares, B Shares, H Shares, Red Chips, P Chips, S Chips and N Shares, where the A Share constituents are available to international investors through Northbound China Stock Connect Scheme, eligible under the scheme’s Buy-And-Sell List. The MSCI China A Onshore Index captures large- and mid-cap representation across China securities listed on the Shanghai and Shenzhen exchanges. Past performance is not an indicator or a guarantee of future performance. Indexes are unmanaged and one cannot invest directly in an index. Important data provider notices and terms available at www.franklintempletondatasources.com.

Volatility is still part of the equation, but for investors with a long-term view and appetite for near-term swings, we believe current entry points may offer potential upside. After years on the sidelines, diversification through Chinese equities may again earn its place in global portfolios.



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.

Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data.  Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.

Franklin Templeton has environmental, social and governance (ESG) capabilities; however, not all strategies or products for a strategy consider “ESG” as part of their investment process.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued in the U.S. by Franklin Templeton, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com. Investments are not FDIC insured; may lose value; and are not bank guaranteed.

You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.